What are the recommended lisinopril dosing guidelines for adults with hypertension and heart failure, including dose adjustments for elderly, volume‑depleted, or renally impaired patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lisinopril Dosing Guidelines

For hypertension, start lisinopril at 10 mg once daily and titrate to a target of 20-40 mg daily; for heart failure, start at 5 mg once daily (or 2.5 mg if hyponatremic or volume-depleted) and titrate to a target of 20-35 mg daily. 1

Hypertension Dosing

Standard Adult Dosing

  • Starting dose: 10 mg once daily 1
  • Target dose: 20-40 mg once daily 2, 1
  • Maximum studied dose: 80 mg daily (though doses above 40 mg provide minimal additional benefit) 1

Patients on Diuretics or Volume-Depleted

  • Starting dose: 5 mg once daily 1
  • This lower starting dose prevents excessive hypotension in patients already taking diuretics or who are volume-depleted
  • After adding a diuretic to lisinopril monotherapy, you may be able to reduce the lisinopril dose 1

Elderly Patients (>80 years) or Frail

  • Consider monotherapy initially 3
  • Start at lower doses and titrate more cautiously
  • Individualize blood pressure targets based on frailty status 3
  • Lisinopril is effective and well-tolerated in elderly patients, with no clinically significant age-related differences in efficacy 4, 5

Heart Failure Dosing

Standard Heart Failure Dosing

  • Starting dose: 5 mg once daily 2, 1
  • Target dose: 20-35 mg once daily 2, 1
  • Maximum dose: 40 mg once daily 1

Heart Failure with Hyponatremia

  • Starting dose: 2.5 mg once daily if serum sodium <130 mEq/L 1
  • Titrate upward as tolerated to maximum of 40 mg daily
  • Adjust diuretic doses to minimize hypovolemia and hypotension 1

Key principle: The appearance of hypotension after the initial dose does not preclude subsequent careful dose titration—manage the hypotension and continue titrating 1. High-dose lisinopril (32.5-35 mg daily) is as effective and well-tolerated in high-risk heart failure patients, including those with diabetes, as in the general heart failure population 6.

Post-Myocardial Infarction Dosing

Hemodynamically Stable Patients

  • Day 1: 5 mg orally within 24 hours of symptom onset 7, 1
  • Day 2: 5 mg 1
  • Day 3: 10 mg 1
  • Maintenance: 10 mg once daily for at least 6 weeks 1

Low Systolic Blood Pressure (≤120 mmHg and >100 mmHg)

  • Starting dose: 2.5 mg during first 3 days 7, 1
  • Then follow standard titration schedule

Hypotension Management During MI

  • If SBP ≤100 mmHg: Give maintenance dose of 5 mg with temporary reductions to 2.5 mg if needed 1
  • If prolonged hypotension (SBP <90 mmHg for >1 hour): Withdraw lisinopril 1

Renal Impairment Dosing

Creatinine Clearance >30 mL/min

  • No dose adjustment required 1

Creatinine Clearance 10-30 mL/min

  • Hypertension: Start at 5 mg once daily (half the usual dose) 1
  • Heart failure: Start at 2.5 mg once daily 1
  • Post-MI: Start at 2.5 mg once daily 1
  • Titrate as tolerated to maximum of 40 mg daily 1

Hemodialysis or Creatinine Clearance <10 mL/min

  • Starting dose: 2.5 mg once daily for all indications 1
  • Lisinopril is effective in patients with impaired renal function without significant deterioration in GFR 8
  • Mean GFR remains unchanged during treatment 8, 5

Important caveat: While ACE inhibitors may cause transient increases in creatinine, these changes are often not clinically relevant when accompanied by appropriate decongestion and diuresis 9. Do not reflexively discontinue ACE inhibitors for small creatinine increases if the patient is improving clinically 10.

Pediatric Dosing (≥6 years with GFR >30 mL/min/1.73m²)

  • Starting dose: 0.07 mg/kg once daily (maximum 5 mg total) 1
  • Target dose: Up to 0.61 mg/kg once daily (maximum 40 mg) 1
  • Not recommended: Children <6 years or with GFR <30 mL/min/1.73m² 1

Titration Strategy

The target dose should be either the dose proven effective in large clinical trials or the maximum tolerated dose 2. If lisinopril appears poorly tolerated (e.g., hypotension, bradycardia, renal dysfunction), re-evaluate other concomitant medications with less proven benefit—reduce or discontinue those drugs to allow better tolerance of lisinopril 2.

Common Pitfalls to Avoid

  1. Don't stop at low doses: Many clinicians fail to uptitrate to target doses. The mortality and morbidity benefits in heart failure come from higher doses (20-35 mg daily) 2.

  2. Don't discontinue for transient hypotension: Initial hypotension can be managed and does not preclude continued titration 1.

  3. Don't avoid in renal impairment: Lisinopril is effective and safe in patients with reduced GFR when dosed appropriately 8, 11. Small increases in creatinine during decongestion are often acceptable 9, 10.

  4. Don't use twice-daily dosing: Despite manufacturer labeling suggesting BID dosing if once-daily is insufficient, real-world evidence shows no improved effectiveness or safety with BID dosing 12. Instead, increase the once-daily dose or add another agent.

  5. Volume status matters: Always assess volume status before initiating or uptitrating. Volume-depleted patients need lower starting doses (5 mg for hypertension, 2.5 mg for heart failure) 1.

References

Research

Lisinopril in elderly patients with hypertension.

Journal of cardiovascular pharmacology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.